Kalaris Therapeutics, Inc. · NASDAQ:KLRS

Srinivas Akkaraju reported a 56.50% stake in Kalaris Therapeutics, Inc. (Schedule 13D/A)

Event Dec 18, 2025 · Filed Feb 17, 2026

Srinivas Akkaraju reported a 56.50% stake in Kalaris Therapeutics, Inc., 12,954,081 shares, with active intent on Dec 18, 2025. Filed Feb 17, 2026 (Schedule 13D/A).

Stake
56.50%
Shares
12,954,081
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
Samsara BioCapital, L.P.47.90%10,968,234
Samsara BioCapital GP, LLC47.90%10,968,234
Samsara Opportunity Fund, L.P.8.60%1,979,847
Samsara Opportunity Fund GP, LLC8.60%1,979,847
Srinivas Akkaraju56.50%12,954,081

Source

View original at SEC

Related